Form 4: BeiGene Executive Sells Shares
Insider Transaction (Form 4)
Chan Henry Lee, SVP, General Counsel of BeiGene, Ltd., sold 2,666 shares of common stock on August 11, 2026 for $360.00 per share.
Summary
- Option exercise/conversion: acquired 812 American Depositary Shares at $194.47 ($157,910) on August 11, 2026; holds 812 after (Direct).
- Option exercise/conversion: acquired 1,058 American Depositary Shares at $213.32 ($225,693) on August 11, 2026; holds 1,870 after (Direct).
- Option exercise/conversion: acquired 796 American Depositary Shares at $159.03 ($126,588) on August 11, 2026; holds 2,666 after (Direct).
- Open-market sale: disposed of 2,666 American Depositary Shares at $360.00 ($959,760) on August 11, 2026 (Direct).
- Option exercise/conversion: disposed of 10,556 Share Option (Right to Buy) on August 11, 2026 (Direct).
- Option exercise/conversion: disposed of 13,754 Share Option (Right to Buy) on August 11, 2026; holds 57,369 after (Direct).
- Option exercise/conversion: disposed of 10,348 Share Option (Right to Buy) on August 11, 2026; holds 88,582 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $959,760 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Chan Henry Lee — Officer (SVP, General Counsel)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | American Depositary Shares | 812 | $194 | $157.9K | 812 |
| 2026-08-11 | Option exercise/conversion | American Depositary Shares | 1,058 | $213 | $225.7K | 1,870 |
| 2026-08-11 | Option exercise/conversion | American Depositary Shares | 796 | $159 | $126.6K | 2,666 |
| 2026-08-11 | Open-market sale | American Depositary Shares | 2,666 | $360 | $959.8K | 0 |
| 2026-08-11 | Option exercise/conversion | Share Option (Right to Buy) | 10,556 | — | — | 0 |
| 2026-08-11 | Option exercise/conversion | Share Option (Right to Buy) | 13,754 | — | — | 57,369 |
| 2026-08-11 | Option exercise/conversion | Share Option (Right to Buy) | 10,348 | — | — | 88,582 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (812 shares) |
| 2026-08-11 | Option exercise/conversion (1,058 shares) |
| 2026-08-11 | Option exercise/conversion (796 shares) |
| 2026-08-11 | Open-market sale (2,666 shares) |
| 2026-08-11 | Option exercise/conversion (10,556 shares) |
| 2026-08-11 | Option exercise/conversion (13,754 shares) |
| 2026-08-11 | Option exercise/conversion (10,348 shares) |
Keywords
insider transaction, Form 4, ONC, BeOne Medicines Ltd., bearish, Chan Henry Lee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.